Mentice AB (publ) receives an order of USD 655,000 for simulation solutions from Medtronic
READ MORE
REGISTER
Mentice Year-end Report Q4, Oct - Dec 2022
READ MORE
REGISTER

Mentice receives an order of USD 655,000 for simulation solutions from Medtronic

Thursday, March 2, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic, Dublin, a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® and physiological flow system simulation solutions for 655,000 USD.

"We are proud that Medtronic has chosen Mentice solutions to support their educational training facility at Medtronic Innovation Center in Istanbul, Turkey,” says Göran Malmberg, the CEO of Mentice. “By utilizing Mentice procedural and device adoption solutions, physicians will have access to the most advanced hands-on learning solutions on the market." 
 
The order will be accounted for in the order book for the business area Medical Device Industry during the second quarter of 2023.

Mentice AB (publ) får en order på simuleringslösningar värd USD 655,000 från Medtronic
LÄS MER
Mentice Bokslutskommuniké, Jan - Dec 2022
LÄS MER

Mentice receives an order of USD 655,000 for simulation solutions from Medtronic

Thursday, March 2, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic, Dublin, a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® and physiological flow system simulation solutions for 655,000 USD.

"We are proud that Medtronic has chosen Mentice solutions to support their educational training facility at Medtronic Innovation Center in Istanbul, Turkey,” says Göran Malmberg, the CEO of Mentice. “By utilizing Mentice procedural and device adoption solutions, physicians will have access to the most advanced hands-on learning solutions on the market." 
 
The order will be accounted for in the order book for the business area Medical Device Industry during the second quarter of 2023.